OXSORALEN-ULTRA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oxsoralen-ultra, and when can generic versions of Oxsoralen-ultra launch?
Oxsoralen-ultra is a drug marketed by Bausch and is included in one NDA.
The generic ingredient in OXSORALEN-ULTRA is methoxsalen. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oxsoralen-ultra
A generic version of OXSORALEN-ULTRA was approved as methoxsalen by STRIDES PHARMA on June 5th, 2014.
Summary for OXSORALEN-ULTRA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 150 |
Clinical Trials: | 1 |
Patent Applications: | 5,327 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in OXSORALEN-ULTRA? | OXSORALEN-ULTRA excipients list |
DailyMed Link: | OXSORALEN-ULTRA at DailyMed |
Recent Clinical Trials for OXSORALEN-ULTRA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
M.D. Anderson Cancer Center | Phase 1 |
National Cancer Institute (NCI) | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for OXSORALEN-ULTRA
US Patents and Regulatory Information for OXSORALEN-ULTRA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bausch | OXSORALEN-ULTRA | methoxsalen | CAPSULE;ORAL | 019600-001 | Oct 30, 1986 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OXSORALEN-ULTRA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | OXSORALEN-ULTRA | methoxsalen | CAPSULE;ORAL | 019600-001 | Oct 30, 1986 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OXSORALEN-ULTRA
See the table below for patents covering OXSORALEN-ULTRA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 1173751 | FORME POSOLOGIQUE DE METHOXSALEN (METHOXSALEN DOSAGE FORMS) | ⤷ Try a Trial |
Israel | 62762 | PHARMACEUTICAL COMPOSITIONS COMPRISING METHOXSALEN | ⤷ Try a Trial |
New Zealand | 196973 | METHOXSALEN COMPOSITIONS | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |